Methodology of induced sputum induction and processing - Recommendation of Polish Respiratory Society;Wskazówki metodologiczne Polskiego Towarzystwa Chorób Płuc odnośnie do wykonywania i oceny plwociny indukowanej

Pneumonologia i Alergologia Polska

Volumn 76, Issue 5, 2008, Pages 378-395

  Chmielowicz, Beata ^a   Obojski, Andrzej ^a   Barczyk, Adam ^b   Sozańska, Ewa ^b   Kycler, Zdzisława ^c   Demkow, Urszula ^d   Domagała Kulawik, Joanna ^d  

^a Akademii Medycznej we Wrocawiu

^b Katedra i Klinika Pneumonologii la skiego

^c III Katedra Pediatrii Uniwersytetu Medycznego Im K Marcinkowskiego w Poznaniu

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; SODIUM CHLORIDE;

ARTICLE; BRONCHOSCOPY; CYTOLOGY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LABORATORY DIAGNOSIS; METHODOLOGY; POLAND; PRACTICE GUIDELINE; RESPIRATORY TRACT DISEASE; SECRETION; SPIROMETRY; SPUTUM;

ADMINISTRATION, INHALATION; BRONCHOSCOPY; HUMANS; POLAND; RESPIRATORY TRACT DISEASES; SALINE SOLUTION, HYPERTONIC; SPECIMEN HANDLING; SPIROMETRY; SPUTUM;

EID: 57049083531     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Paggiaro P.L., Chanez P., Holz O. i wsp. Sputum induction. Eur. Respir. J. 2002; 20 (supl. 37): 3-8.
2. Bhowmik A., Seemungal T.A., Sapsford R.J. i wsp. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax 1998; 53: 953-956.
3. Kelly M.M., Keatings V., Leigh R. i wsp. Analysis of fluid-phase mediators. Eur. Respir. J. 2002; 20 (supl. 37): 24-39.
4. Pizzichini E., Pizzichini M.M., Efthimiadis A. i wsp. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am. J. Respir. Crit. Care Med. 1996; 154: 308-317.
5. Pavord I.D., Sterk P.J., Hargreave F.E. i wsp. Clinical applications of assessment of airway inflammation using induced sputum. Eur. Respir. J. Suppl. 2002; 37: 40-43.
6. Fireman E. Induced sputum: opening a new window to the lung. Sarcoidosis. Vase. Diffuse. Lung. Dis. 2001; 18: 263-271.
7. Fireman E., Topilsky I., Greif J. i wsp. Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease. Respir. Med. 1999; 93: 827-834.
8. Lovett C.J., Whitehead B.F., Gibson P.G. Eosinophilic airway inflammation and the prognosis of childhood asthma. Clin. Exp. Allergy 2007; 37: 1594-1601.
9. Gibson P.G., Simpson J.L., Hankin R. i wsp. Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma. Thorax 2003; 58: 116-121.
10. Sagel S.D., Kapsner R., Osberg I. i wsp. Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. Am. J. Respir. Crit. Care Med. 2001; 164:1425-1431.
11. Mayer-Hamblett N., Aitken M.L., Accurso F.J. i wsp. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2007; 175: 822-828.
12. Dakin C.J., Pereira J.K., Henry R.L. i wsp. Relationship between sputum inflammatory markers, lung function, and lung pathology on high-resolution computed tomography in children with cystic fibrosis. Pediatr. Pulmonol. 2002; 33: 475-482.
13. Pradal M., Retornaz K., Poisson A. Chronic cough in childhood. Rev. Mal. Respir. 2004; 21: 743-762.
14. Guran T., Ersu R., Karadag B. i wsp. Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis. Pediatr. Pulmonol. 2007; 42: 362-369.
15. Gibson P.G., Simpson J.L., Chalmers A.C. i wsp. Airway eosinophilia is associated with wheeze but is uncommon in children with persistent cough and frequent chest colds. Am. J. Respir. Crit. Care Med. 2001; 164: 977-981.
16. Li A.M., Hung E., Tsang T. i wsp. Induced sputum inflammatory measures correlate with disease severity in children with obstructive sleep apnoea. Thorax 2007; 62: 75-79.
17. Zihlif N., Paraskakis E., Tripoli C. i wsp. Markers of airway inflammation in primary ciliary dyskinesia studied using exhaled breath condensate. Pediatr. Pulmonol. 2006; 41: 509-514.
18. Zar H.J., Tannenbaum E., Hanslo D. i wsp. Sputum induction as a diagnostic tool for community-acquired pneumonia in infants and young children from a high HIV prevalence area. Pediatr. Pulmonol. 2003; 36: 58-62.
19. Zar H.J., Hanslo D., Apolles P. i wsp. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005; 365: 130-134.
20. Soferman R., Fireman E. The assessment of induced sputum in detecting Aspergillus fumigatus hyphae in steroid-dependent unstable asthma. Allergy 2006; 61: 1150-1151.
21. Zacharasiewicz A., Erin E.M., Bush A. Noninvasive monitoring of airway inflammation and steroid reduction in children with asthma. Curr. Opin. Allergy Clin. Immunol. 2006; 6:155-160.
22. Górski P., Szmidt M., Grupa robocza: Testy prowokacyjne w alergii wziewnej. Standardy w alergologii, czȩść I. Pod patronatem Zarza̧du Głównego Polskiego Towarzystwa Alergologicznego. The UCB Istitute of Allergy, Belgia 2003; 37-42.
23. Miller M.R., Hankinson J., Brusasco V. i wsp. ATS/ERS Task Force. Standardisaton on spirometry. Eur. Respir. J. 2005; 26: 319-338.
24. Zalecenia Polskiego Towarzystwa Chorob Płuc dotycza̧ce wykonywania badań spirometrycznych. Franczuk M., Antczak A. (red.). Pneumonol. Alergol. Pol. 2006; (supl. 1). 74: 13-16.
25. Covar R.A., Spahn J.D., Martin R.J. i wsp. Safety and application of induced sputum analysis in childhood asthma. J. Allergy Clin. Immunol. 2004; 114: 575-582.
26. Gibson P.G., Grootendor D.C., Henry R.L. i wsp. Sputum induction in children. Eur. Respir. J. 2002; 20: 44-46.
27. Suri R., Marshall L.J., Wallis C. i wsp. Safety and use of sputum induction in children with cystic fibrosis. Pediatr. Pulmonol. 2003; 35: 309-313.
28. Jones P.D., Hankin R., Simpson J. i wsp. The tolerability, safety, and success of sputum induction and combined hypertonic saline challenge in children. Am. J. Respir. Crit. Care Med. 2001; 164: 1146-1149.
29. Spanevello A., Beghe B., Bianchi A. i wsp. Comparison of two methods of processing induced sputum: selected versus entire sputum. Am. J. Respir. Crit. Care Med. 1998; 157: 665-668.
30. Pin I., Gibson P.G., Kolendowicz R. i wsp. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-29.
31. Fahy J.V., Liu J., Wong H. i wsp. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J. Allergy Clin. Immunol. 1994; 93: 1031-1039.
32. Efthimiadis A., Spanevello A., Hamid Q. i wsp. Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur. Respir. J. 2002; 37: 19-23.
33. Efthimiadis A., Jayaram L., Weston S. i wsp. Induced sputum: time from expectoration to processing. Eur. Respir. J. 2002; 19: 706-708.
34. Popov T., Gottschalk R., Kolendowicz R. i wsp. The evaluation of a cell dispersion method of sputum examination. Clin. Exp. Allergy 1994; 24: 778-783.
35. Popov T.A., Pizzichini M.M., Pizzichini E. i wsp. Some technical factors influencing the induction of sputum for cell analysis. Eur. Respir. J. 1995; 8: 559-565.
36. Pavord I.D., Pizzichini M.M., Pizzichini E. i wsp. The use of induced sputum to investigate airway inflammation. Thorax 1997; 52: 498-501.
37. Jayaram L., Parameswaran K., Sears M.R. i wsp. Induced sputum cell counts: their usefulness in clinical practice. Eur. Respir. J. 2000; 16: 150-158.
38. Gershman N.H., Wong H.H., Liu J.T. i wsp. Comparison of two methods of collecting induced sputum in asthmatic subjects. Eur. Respir. J. 1996; 9: 2448-2453.
39. Efthimiadis A., Pizzichini M.M., Pizzichini E. i wsp. Induced sputum cell and fluid-phase indices of inflammation: comparison of treatment with dithiothreitol vs phosphate-buffered saline. Eur. Respir. J. 1997; 10: 1336-1340.
40. Pizzichini M.M., Popov T.A., Efthimiadis A. i wsp. Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 1996; 154: 866-869.
41. Sozańska E., Ga̧sior G., Semik A. i wsp. Zakres wartości prawidłowych dla komórek wystȩpuja̧ cych w indukowanej plwocinie w populacji śla̧skiej. Pneumonol. Alergol. Pol. 2005; 73: 148-152.
42. Pizzichini E., Pizzichini M.M., Efthimiadis A. i wsp. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur. Respir. J. 1996; 9: 1174-1180.
43. Fleury-Feith J., Escudier E., Pocholle M.J. i wsp. The effects of cytocentrifugation on differential cell counts in samples obtained by bronchoalveolar lavage. Acta. Cytol. 1987; 31: 606-610.
44. Gauvreau G.M., Lee J.M., Watson R.M. i wsp. Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am. J. Respir. Crit. Care Med. 2000; 161: 1473-1478.
45. Kelly M.M., Hargreave F.E., Cox G. A method to preserve sputum for delayed examination. Eur. Respir. J. 2003; 22: 996-1000.
46. Wooten O.J., Dulfano M.J. Improved homogenization techniques for sputum cytology counts. Ann. Allergy 1978; 41:150-154.
47. Saraiva-Romanholo B.M., Barnabe V., Carvalho A.L. i wsp. Comparison of three methods for differential cell count in induced sputum. Chest 2003; 124: 1060-1066.
48. Rytila P., Metso T., Petays T. i wsp. Eosinophilic airway inflammation as an underlying mechanism of undiagnosed prolonged cough in primary healthcare patients. Respir. Med. 2002; 96: 52-58.
49. Metso T., Rytila P., Peterson C. i wsp. Granulocyte markers in induced sputum in patients with respiratory disorders and healthy persons obtained by two sputum-processing methods. Respir. Med. 2001; 95: 48-55.
50. Ronchi M.C., Galli G., Zonefrati R. i wsp. Sputum processing: a new method to improve cytospin quality. Clin. Exp. Allergy 2002; 32: 674-680.
51. Pignatti P., Delmastro M., Perfetti L. i wsp. Is dithiothreitol affecting cells and soluble mediators during sputum processing? A modified methodology to process sputum. J. Allergy Clin. Immunol. 2002; 110: 667-668.
52. Mamessier E., Boniface S., Dupuy P. i wsp. Study of cytokine gene expression in small cell samples: use in induced sputum. J. Immunol. Methods 2003; 280: 37-47.
53. Louis R., Shute J., Goldring K. i wsp. The effect of processing on inflammatory markers in induced sputum. Eur. Respir. J. 1999; 13: 660-667.
54. Grebski E., Peterson C., Medici T.C. Effect of physical and chemical methods of homogenization on inflammatory mediators in sputum of asthma patients. Chest 2001; 119: 1521-1525.
55. Qiu D., Tan W.C. Dithiothreitol has a dose-response effect on cell surface antigen expression. J. Allergy Clin. Immunol. 1999; 103: 873-876.
56. Kim J.S., Hackley G.H., Okamoto K. i wsp. Sputum processing for evaluation of inflammatory mediators. Pediatr. Pulmonol. 2001; 32: 152-158.
57. Barczyk A., Pierzchala W., Sozańska E. Stȩzenia CC-chemokin (MCP-1, MIP-1α, MIP-1β) w indukowanej plwocinie u chorych na przewlekła̧ obturacyjna̧ chorobȩ płuc i u chorych na przewlekle zapalenie oskrzeli. Pneumonol. Alergol. Pol. 2001; 69: 40-49.
58. Prince P., Bertrand M., Boulay M.E. i wsp. Optimization of the conditions for preservation of induced sputum: influence of freezing on cellular analysis. Chest 2005; 128: 980-985.
59. Keatings V.M., Barnes P.J. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am. J. Respir. Crit. Care Med. 1997; 155: 449-453.
60. Domagala-Kulawik J. Trudności interpretacyjne w ocenie rozmazów komórkowych BAL i plwociny indukowanej. Pneumonol. Alergol. Pol. 2007; 75: 261-267.
61. Thomas R.A., Green R.H., Brightling C.E. i wsp. The influence of age on induced sputum differential cell counts in normal subjects. Chest 2004; 126: 1811-1814.
62. Belda J., Leigh R., Parameswaran K. i wsp. Induced sputum cell counts in healthy adults. Am. J. Respir. Crit. Care Med. 2000; 161: 475-478.
63. Domagala-Kulawik J., Maskey-Warzechowska M., Hermanowicz-Salamon J. i wsp. Expression of macrophage surface markers in induced sputum of patients with chronic obstructive pulmonary disease. J. Physiol. Pharmacol. 2006; 57 (supl. 4): 75-84.
64. Spanevello A., Confalonieri M., Sulotto F i wsp. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am. J. Respir. Crit. Care Med. 2000; 162: 1172-1174.
65. Cataldo D., Foidart J.M., Lau L. i wsp. Induced sputum. Comparison between isotonic and hypertonic saline solution inhalation in patients with asthma. Chest 2001; 120: 1815-1821.
66. Cianchetti S., Bacci E., Ruocco L. i wsp. Granulocyte markers in hypertonic and isotonic saline-induced sputum of asthmatic subjects. Eur. Respir. J. 2004; 24: 1018-1024.
67. Belda J., Hussack P., Dolovich M. i wsp. Sputum induction: effect of nebulizer output and inhalation time on cell counts and fluid-phase measures. Clin. Exp. Allergy 2001; 31: 1740-1744.
68. Kelly M.G., Brown V., Martin S.L. i wsp. Comparison of sputum induction using high-output and low-output ultrasonic nebulizers in normal subjects and patients with COPD. Chest 2002; 122: 955-959.
69. Richter K., Holz O., Jörres R.A. i wsp. Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease. Eur. Respir. J. 1999; 14: 697-701.
70. Nightingale J.A., Rogers D.F., Barnes P.J. Effect of repeated sputum induction on cell counts in normal volunteers. Thorax 1998; 53: 87-90.
71. Holz O., Richter K., Jorres R.A. i wsp. Changes in sputum composition between two inductions performed on consecutive days. Thorax 1998; 53: 83-86.
72. Simpson J.L., Timmins N.L., Fakes K. i wsp. Effect of saliva contamination on induced sputum cell counts, IL-8 and eosino-phil cationic protein levels. Eur. Respir. J. 2004; 23: 759-762.
73. Erin E.M., Barnes P.J., Hansel T.T. Optimizing sputum methodology. Clin. Exp. Allergy 2002; 32: 653-657.
74. Woolhouse I.S., Bayley D.L., Stockley R.A. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax 2002;57:667-671.
75. Kelly M.M., Leigh R., Carruthers S. i wsp. Increased detection of interleukin-5 in sputum by addition of protease inhibitors. Eur. Respir. J. 2001; 18: 685-691.
76. Kelly M.M., Leigh R., Horsewood P. i wsp. Induced sputum: validity of fluid-phase IL-5 measurement. J. Allergy Clin. Immunol. 2000; 105:1162-1168.
77. Simpson J.L., Gibson P.G., Wark P.A. Optimization of sputum-processing methods for the measurement of interleukin-5: effects of protease inhibition. Respirology 2002; 7: 111-116.
78. Loppow D., Bottcher M., Gercken G. i wsp. Flow cytometric analysis of the effect of dithiothreitol on leukocyte surface markers. Eur. Respir. J. 2000; 16: 324-329.
79. van Overveld F.J., Demkow U., Gorecka D. i wsp. Effects of homogenization of induced sputum by dithiothreitol on polymorphonuclear cells. J. Physiol. Pharmacol. 2005; 56: 143-154.
80. van der Voort P.H., Postma D.S., Timens W. i wsp. Acute effects of cigarette smoking on inflammation in healthy intermittent smokers. Respir. Res. 2005; 6: 22.
81. Lensmar C., Elmberger G., Sandgren P. i wsp. Leukocyte counts and macrophage phenotypes in induced sputum and broncho-alveolar lavage fluid from normal subjects. Eur. Respir. J. 1998; 12: 595-600.
82. Frankenberger M., Menzel M., Betz R. i wsp. Characterization of a population of small macrophages in induced sputum of patients with chronic obstructive pulmonary disease and healthy volunteers. Clin. Exp. Immunol. 2004; 138: 507-516.
83. Domagala-Kulawik J., Maskey-Warzechowska M., Kraszewska I. i wsp. The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD. Chest 2003; 123: 1054-1059.
84. Gamble E., Grootendorst D.C., Hattotuwa K. i wsp. Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: apooled analysis. Eur. Respir. J. 2007; 30: 467-471.
85. Willemse B.W., Postma D.S., Timens W. i wsp. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur. Respir. J. 2004; 23: 464-476.
86. Kycler Z. Badanie indukowanej plwociny w ocenie zapalenia u dzieci chorych na astmȩ oskrzelowa̧. Rozprawa doktorska. AM Poznań 2006.